A Study to Assess the Steady-State Bioequivalence of Once-Weekly Corplex Donepezil Transdermal Delivery System Compared to Daily Oral Administration of Aricept

Trial Profile

A Study to Assess the Steady-State Bioequivalence of Once-Weekly Corplex Donepezil Transdermal Delivery System Compared to Daily Oral Administration of Aricept

Recruiting
Phase of Trial: Phase I

Latest Information Update: 30 Aug 2017

At a glance

  • Drugs Donepezil (Primary) ; Donepezil
  • Indications Alzheimer's disease
  • Focus Pharmacokinetics; Registrational
  • Sponsors Corium International
  • Most Recent Events

    • 24 Aug 2017 Planned number of patients changed from 86 to 60.
    • 24 Aug 2017 Planned End Date changed from 1 Jul 2018 to 1 Aug 2018.
    • 24 Aug 2017 Planned primary completion date changed from 1 Mar 2018 to 1 Apr 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top